Chr9p deletion spans the CDKN2A tumour suppressor commonly altered in the CIN subgroup of gastric (roughly 41%; Extended Data Fig. 2a) and oesophageal (roughly 74%) adenocarcinomas, and co-occurs with TP53 alterations19,22. Here, TP53 is linked to cervical squamous intraepithelial neoplasia.